Related Experiment Video
Updated: Apr 23, 2026

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
Published on: February 9, 2024
Characterization and complete genome sequence of a novel N4-like bacteriophage, pSb-1 infecting Shigella boydii
Jin Woo Jun1, Sae Kil Yun2, Hyoun Joong Kim2
1Institute of Marine Biology, Biotechnology and Aquaculture, Hellenic Centre for Marine Research, Former American Base of Gournes, Heraklion 71003, Crete, Greece; Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 151-742, Republic of Korea.
Abstract:
Shigellosis is one of major foodborne pathogens in both developed and developing countries. Although antibiotic therapy is considered an effective treatment for shigellosis, the imprudent use of antibiotics has led to the increase of multiple-antibiotic-resistant Shigella species globally. In this study, we isolated a virulent Podoviridae bacteriophage (phage), pSb-1, that infects Shigella boydii. One-step growth analysis revealed that this phage has a short latent period (15 min) and a large burst size (152.63 PFU/cell), indicating that pSb-1 has good host infectivity and effective lytic activity. The double-stranded DNA genome of pSb-1 is composed of 71,629 bp with a G + C content of 42.74%. The genome encodes 103 putative ORFs, 9 putative promoters, 21 transcriptional terminators, and one tRNA region. Genome sequence analysis of pSb-1 and comparative analysis with the homologous phage EC1-UPM, N4-like phage revealed that there is a high degree of similarity (94%, nucleotide sequence identity) between pSb-1 and EC1-UPM in 73 of the 103 ORFs of pSb-1. The results of this investigation indicate that pSb-1 is a novel virulent N4-like phage infecting S. boydii and that this phage might have potential uses against shigellosis.
Insights
Researchers discovered a novel bacteriophage, pSb-1, effective against Shigella boydii. This virulent phage shows promise as a therapeutic agent against shigellosis, a common foodborne illness.
Area of Science:
- Microbiology
- Virology
- Genomics
Background:
- Shigellosis is a significant foodborne illness globally.
- Rising antibiotic resistance in Shigella necessitates alternative treatments.
Purpose of the Study:
- To isolate and characterize a novel bacteriophage targeting Shigella boydii.
- To evaluate the potential of this phage as a therapeutic agent against shigellosis.
Main Methods:
- Isolation and characterization of bacteriophage pSb-1.
- One-step growth analysis to determine phage replication parameters.
- Genome sequencing and comparative genomic analysis.
Main Results:
- Phage pSb-1 exhibits a short latent period (15 min) and high burst size (152.63 PFU/cell).
- The double-stranded DNA genome is 71,629 bp with 103 putative ORFs.
- pSb-1 shares 94% nucleotide sequence identity with the N4-like phage EC1-UPM.
Conclusions:
- pSb-1 is a novel, virulent N4-like bacteriophage that infects Shigella boydii.
- Phage pSb-1 demonstrates significant potential for combating shigellosis.
Related Concept Videos
DNA Bacteriophages
Viral Replication: Lytic Cycle
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Bacterial Gastroenteritis
Bacterial Phylum Bacteroidota

